Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Bevacizumab 26 Cetuximab 24 Fluorouracil 23 Leucovorin 22 Oxaliplatin 19 pembrolizumab 18 Specimen Handling 11 Irinotecan 10 Nivolumab 8 Magnetic Resonance Spectroscopy 8 atezolizumab 7 Biopsy 7 Pemetrexed 6 Panitumumab 6 Cisplatin 6 Carboplatin 6 trifluridine tipiracil drug combination 5 fludarabine 5 encorafenib 5 HMPL-013 5 Gemcitabine 5 Folfox protocol 5 Standard of Care 4 Immunoglobulin G 4 Disulfides 4 Cyclophosphamide 4 zanidatamab 3 regorafenib 3 fludarabine phosphate 3 dehydroftorafur 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Colorectal Neoplasms × leronlimab × 30 days × Clear all

NCT06699836 2026-05-18

CLOVER

CytoDyn, Inc.

Phase 2 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡